arden hemacare limited
arden hemacare limited Company Information
Company Number
08861642
Registered Address
c/o 12 sharmans cross road, solihull, west midlands, B91 1RG
Industry
Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
Telephone
-
Next Accounts Due
April 2024
Group Structure
View All
Shareholders
joseph debono 37.5%
leno birch hansen 37.5%
View Allarden hemacare limited Estimated Valuation
The estimated valuation range for arden hemacare limited, derived from financial data as of January 2018 and the most recent industry multiples, is between £0 to £714.6k
arden hemacare limited Estimated Valuation
The estimated valuation range for arden hemacare limited, derived from financial data as of January 2018 and the most recent industry multiples, is between £0 to £714.6k
arden hemacare limited Estimated Valuation
The estimated valuation range for arden hemacare limited, derived from financial data as of January 2018 and the most recent industry multiples, is between £0 to £714.6k
Get a detailed valuation report, edit figures and unlock valuation multiples.
Arden Hemacare Limited AI Business Plan
In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.
Arden Hemacare Limited Overview
Arden Hemacare Limited is a dissolved company that was located in west midlands, B91 1RG with a Companies House number of 08861642. It operated in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in January 2014, it's largest shareholder was joseph debono with a 37.5% stake. The last turnover for Arden Hemacare Limited was estimated at £3.1m.
Upgrade for unlimited company reports & a free credit check
Arden Hemacare Limited Health Check
Pomanda's financial health check has awarded Arden Hemacare Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 6 areas for improvement. Company Health Check FAQs
3 Strong
2 Regular
6 Weak
Size
annual sales of £3.1m, make it smaller than the average company (£6.4m)
- Arden Hemacare Limited
£6.4m - Industry AVG
Growth
3 year (CAGR) sales growth of 165%, show it is growing at a faster rate (9.7%)
- Arden Hemacare Limited
9.7% - Industry AVG
Production
with a gross margin of 27.4%, this company has a higher cost of product (34.8%)
- Arden Hemacare Limited
34.8% - Industry AVG
Profitability
an operating margin of -6.2% make it less profitable than the average company (5.2%)
- Arden Hemacare Limited
5.2% - Industry AVG
Employees
with 10 employees, this is below the industry average (27)
- Arden Hemacare Limited
27 - Industry AVG
Pay Structure
on an average salary of £48.8k, the company has an equivalent pay structure (£48.8k)
- Arden Hemacare Limited
£48.8k - Industry AVG
Efficiency
resulting in sales per employee of £305.7k, this is more efficient (£245.7k)
- Arden Hemacare Limited
£245.7k - Industry AVG
Debtor Days
it gets paid by customers after 58 days, this is near the average (53 days)
- Arden Hemacare Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 207 days, this is slower than average (40 days)
- Arden Hemacare Limited
40 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Arden Hemacare Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (9 weeks)
0 weeks - Arden Hemacare Limited
9 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 124.4%, this is a higher level of debt than the average (58.9%)
124.4% - Arden Hemacare Limited
58.9% - Industry AVG
arden hemacare limited Credit Report and Business Information
Arden Hemacare Limited Competitor Analysis
Perform a competitor analysis for arden hemacare limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
arden hemacare limited Ownership
ARDEN HEMACARE LIMITED group structure
Arden Hemacare Limited has no subsidiary companies.
Ultimate parent company
ARDEN HEMACARE LIMITED
08861642
arden hemacare limited directors
Arden Hemacare Limited currently has 2 directors. The longest serving directors include Mr Joseph Debono (Jan 2014) and Mr Hans-Georg Langer (Aug 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Joseph Debono | United Kingdom | 75 years | Jan 2014 | - | Director |
| Mr Hans-Georg Langer | United Kingdom | 76 years | Aug 2018 | - | Director |
ARDEN HEMACARE LIMITED financials
Arden Hemacare Limited's latest turnover from January 2018 is estimated at £3.1 million and the company has net assets of -£246.9 thousand. According to their latest financial statements, we estimate that Arden Hemacare Limited has 10 employees and maintains cash reserves of £11.1 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
|---|---|---|---|---|
| Turnover | ||||
| Other Income Or Grants | ||||
| Cost Of Sales | ||||
| Gross Profit | ||||
| Admin Expenses | ||||
| Operating Profit | ||||
| Interest Payable | ||||
| Interest Receivable | ||||
| Pre-Tax Profit | ||||
| Tax | ||||
| Profit After Tax | ||||
| Dividends Paid | ||||
| Retained Profit | ||||
| Employee Costs | ||||
| Number Of Employees | ||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
|---|---|---|---|---|
| Tangible Assets | 2,459 | 2,720 | 0 | 0 |
| Intangible Assets | 471,350 | 306,932 | 42,500 | 0 |
| Investments & Other | 41,356 | 33,926 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 515,165 | 343,578 | 42,500 | 0 |
| Stock & work in progress | 0 | 138,152 | 0 | 0 |
| Trade Debtors | 487,730 | 131,557 | 100,156 | 38,506 |
| Group Debtors | 0 | 0 | 0 | 0 |
| Misc Debtors | 0 | 0 | 0 | 0 |
| Cash | 11,138 | 58,313 | 3,216 | 3,146 |
| misc current assets | 0 | 0 | 0 | 0 |
| total current assets | 498,868 | 328,022 | 103,372 | 41,652 |
| total assets | 1,014,033 | 671,600 | 145,872 | 41,652 |
| Bank overdraft | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 |
| Trade Creditors | 1,260,919 | 729,738 | 164,135 | 51,205 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 |
| total current liabilities | 1,260,919 | 729,738 | 164,135 | 51,205 |
| loans | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 |
| total long term liabilities | 0 | 0 | 0 | 0 |
| total liabilities | 1,260,919 | 729,738 | 164,135 | 51,205 |
| net assets | -246,886 | -58,138 | -18,263 | -9,553 |
| total shareholders funds | -246,886 | -58,138 | -18,263 | -9,553 |
| Jan 2018 | Jan 2017 | Jan 2016 | Jan 2015 | |
|---|---|---|---|---|
| Operating Activities | ||||
| Operating Profit | ||||
| Depreciation | 785 | 680 | 0 | 0 |
| Amortisation | 38,032 | 14,651 | 7,500 | 0 |
| Tax | ||||
| Stock | -138,152 | 138,152 | 0 | 0 |
| Debtors | 356,173 | 31,401 | 61,650 | 38,506 |
| Creditors | 531,181 | 565,603 | 112,930 | 51,205 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||
| Investing Activities | ||||
| capital expenditure | ||||
| Change in Investments | 7,430 | 33,926 | 0 | 0 |
| cash flow from investments | ||||
| Financing Activities | ||||
| Bank loans | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 |
| share issue | ||||
| interest | ||||
| cash flow from financing | ||||
| cash and cash equivalents | ||||
| cash | -47,175 | 55,097 | 70 | 3,146 |
| overdraft | 0 | 0 | 0 | 0 |
| change in cash | -47,175 | 55,097 | 70 | 3,146 |
P&L
January 2018turnover
3.1m
+231%
operating profit
-188.9k
0%
gross margin
27.5%
-3.42%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
January 2018net assets
-246.9k
+3.25%
total assets
1m
+0.51%
cash
11.1k
-0.81%
net assets
Total assets minus all liabilities
arden hemacare limited company details
company number
08861642
Type
Private limited with Share Capital
industry
47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores
incorporation date
January 2014
age
10
accounts
Unaudited Abridged
ultimate parent company
previous names
hematris uk limited (August 2016)
incorporated
UK
address
c/o 12 sharmans cross road, solihull, west midlands, B91 1RG
last accounts submitted
January 2018
arden hemacare limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to arden hemacare limited.
arden hemacare limited Companies House Filings - See Documents
| date | description | view/download |
|---|
